These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Inferring modulators of genetic interactions with epistatic nested effects models. Pirkl M; Diekmann M; van der Wees M; Beerenwinkel N; Fröhlich H; Markowetz F PLoS Comput Biol; 2017 Apr; 13(4):e1005496. PubMed ID: 28406896 [TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of fitness and genetic interactions in yeast on a genome scale. Baryshnikova A; Costanzo M; Kim Y; Ding H; Koh J; Toufighi K; Youn JY; Ou J; San Luis BJ; Bandyopadhyay S; Hibbs M; Hess D; Gingras AC; Bader GD; Troyanskaya OG; Brown GW; Andrews B; Boone C; Myers CL Nat Methods; 2010 Dec; 7(12):1017-24. PubMed ID: 21076421 [TBL] [Abstract][Full Text] [Related]
9. Transcriptional compensation for gene loss plays a minor role in maintaining genetic robustness in Saccharomyces cerevisiae. Wong SL; Roth FP Genetics; 2005 Oct; 171(2):829-33. PubMed ID: 15998714 [TBL] [Abstract][Full Text] [Related]
10. Identifying collateral and synthetic lethal vulnerabilities within the DNA-damage response. Pinoli P; Srihari S; Wong L; Ceri S BMC Bioinformatics; 2021 May; 22(1):250. PubMed ID: 33992077 [TBL] [Abstract][Full Text] [Related]
11. Prediction of Genetic Interactions Using Machine Learning and Network Properties. Madhukar NS; Elemento O; Pandey G Front Bioeng Biotechnol; 2015; 3():172. PubMed ID: 26579514 [TBL] [Abstract][Full Text] [Related]
12. Identifying actionable synthetically lethal cancer gene pairs using mutual exclusivity. Wooller SK; Pearl LH; Pearl FMG FEBS Lett; 2024 Aug; 598(16):2028-2039. PubMed ID: 38977941 [TBL] [Abstract][Full Text] [Related]
13. Synthetic lethal combinations of low-toxicity drugs for breast cancer identified Marhold M; Tomasich E; Schwarz M; Udovica S; Heinzel A; Mayer P; Horak P; Perco P; Krainer M Oncotarget; 2018 Nov; 9(91):36379-36391. PubMed ID: 30555636 [TBL] [Abstract][Full Text] [Related]
14. Computational Approaches to Identify Genetic Interactions for Cancer Therapeutics. Benstead-Hume G; Wooller SK; Pearl FMG J Integr Bioinform; 2017 Sep; 14(3):. PubMed ID: 28941356 [TBL] [Abstract][Full Text] [Related]
15. High throughput RNAi screening identifies ID1 as a synthetic sick/lethal gene interacting with the common TP53 mutation R175H. Imai H; Kato S; Sakamoto Y; Kakudo Y; Shimodaira H; Ishioka C Oncol Rep; 2014 Mar; 31(3):1043-50. PubMed ID: 24378760 [TBL] [Abstract][Full Text] [Related]